ADMP

Adamis Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Adamis Pharmaceuticals Corporation ADMP NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 0.5774 0.00 0.00 0.00 0.5774 08:27:11
more quote information »

Recent News

Date Time Source Heading
7/01/202009:00GLOBEAdamis Pharmaceuticals Provides Update on SYMJEPI Products
6/30/202006:31EDGARSmall Company Offering and Sale of Securities Without..
6/30/202006:30EDGARProxy Statement - Notice of Shareholders Meeting..
6/22/202016:19EDGARCurrent Report Filing (8-k)
6/22/202016:16EDGARCurrent Report Filing (8-k)
6/18/202009:00GLOBEAdamis Pharmaceuticals Announces Publication of..
6/16/202016:49EDGARCurrent Report Filing (8-k)
6/15/202009:00GLOBEAdamis Pharmaceuticals Announces License to Commercialize..
6/12/202017:17EDGARCurrent Report Filing (8-k)
5/27/202009:00GLOBEAdamis Pharmaceuticals Announces Publication of..
5/20/202016:11EDGARStatement of Changes in Beneficial Ownership (4)
5/20/202016:10EDGARStatement of Changes in Beneficial Ownership (4)
5/20/202016:08EDGARStatement of Changes in Beneficial Ownership (4)
5/20/202016:07EDGARStatement of Changes in Beneficial Ownership (4)
5/20/202016:07EDGARStatement of Changes in Beneficial Ownership (4)
5/18/202016:58EDGARCurrent Report Filing (8-k)
5/18/202016:35GLOBEAdamis Pharmaceuticals Announces First Quarter 2020..
5/18/202016:24EDGARQuarterly Report (10-q)
5/18/202009:00GLOBEAdamis Pharmaceuticals Resubmits ZIMHI New Drug Application..
5/15/202009:00GLOBEAdamis Pharmaceuticals Schedules First Quarter 2020 Earnings..
5/13/202017:20EDGARCurrent Report Filing (8-k)
5/12/202006:06EDGARNotification That Quarterly Report Will Be Submitted Late..
5/11/202020:35GLOBEAdamis Pharmaceuticals Provides Update on SYMJEPI Products..
4/29/202016:59EDGARAmended Annual Report (10-k/a)
4/28/202006:06EDGARCurrent Report Filing (8-k)
4/23/202009:00GLOBEAdamis Pharmaceuticals Announces Publication Demonstrating..
4/21/202009:00GLOBEAdamis Pharmaceuticals Announces Production of Additional..
4/17/202016:14EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
4/15/202017:17EDGARCurrent Report Filing (8-k)
4/15/202016:05GLOBEAdamis Pharmaceuticals Announces Receipt of Loan Proceeds..
4/01/202009:00GLOBEAdamis Pharmaceuticals Announces Production of Products by..
3/30/202016:51EDGARCurrent Report Filing (8-k)
3/30/202016:40GLOBEAdamis Pharmaceuticals Announces 2019 Financial Results and..
3/19/202018:42EDGARStatement of Changes in Beneficial Ownership (4)
3/19/202018:41EDGARStatement of Changes in Beneficial Ownership (4)
3/19/202018:40EDGARStatement of Changes in Beneficial Ownership (4)
3/19/202018:37EDGARStatement of Changes in Beneficial Ownership (4)
3/19/202018:36EDGARStatement of Changes in Beneficial Ownership (4)
3/16/202017:17EDGARNotification That Annual Report Will Be Submitted Late (nt..
3/06/202016:46EDGARSmall Company Offering and Sale of Securities Without..
2/28/202009:34EDGARStatement of Ownership (sc 13g)
2/26/202018:35EDGARStatement of Changes in Beneficial Ownership (4)
2/26/202018:02EDGARStatement of Changes in Beneficial Ownership (4)
2/26/202018:01EDGARStatement of Changes in Beneficial Ownership (4)
2/26/202018:00EDGARStatement of Changes in Beneficial Ownership (4)
2/26/202017:59EDGARStatement of Changes in Beneficial Ownership (4)
2/26/202016:54EDGARAnnual Statement of Changes in Beneficial Ownership (5)
2/24/202017:17EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/21/202017:25EDGARCurrent Report Filing (8-k)
2/21/202009:15GLOBEAdamis Pharmaceuticals Announces Pricing of $6.7 Million..
See more news about this stock »
Your Recent History
NASDAQ
ADMP
Adamis Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200713 12:47:18